Adaptive physiological water conservation explains hypertension and muscle catabolism in experimental chronic renal failure by Kovarik, J. et al.
Acta Physiologica. 2021;232:e13629.    |  1 of 19
https://doi.org/10.1111/apha.13629
wileyonlinelibrary.com/journal/apha
Received: 13 September 2020 | Revised: 11 February 2021 | Accepted: 11 February 2021
DOI: 10.1111/apha.13629  
R E G U L A R  P A P E R
Adaptive physiological water conservation explains hypertension 
and muscle catabolism in experimental chronic renal failure
Johannes J. Kovarik1,2  |   Norihiko Morisawa3 |   Johannes Wild4  |   Adriana Marton1  | 
Kaoru Takase- Minegishi1,5 |   Shintaro Minegishi1,6 |   Steffen Daub4 |   Jeff M. Sands7  |   
Janet D. Klein7 |   James L. Bailey7 |   Jean- Paul Kovalik1 |   Manfred Rauh8 |   
Susanne Karbach4 |   Karl F. Hilgers9 |   Friedrich Luft10  |   Akira Nishiyama3 |   
Daisuke Nakano3 |   Kento Kitada1,11 |   Jens Titze1,9,12
1Programme in Cardiovascular and Metabolic Disorders, Duke- NUS Medical School, Singapore, Singapore
2Clinical Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
3Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan
4Division for Cardiology 1, Centre for Cardiology, Johannes Gutenberg- University Mainz, Mainz, Germany
5Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan
6Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
7Renal Division, Department of Medicine, Emory University, Atlanta, GA, USA
8Division of Paediatrics, Research Laboratory, Erlangen, Germany
9Division of Nephrology and Hypertension, University Clinic Erlangen, Erlangen, Germany
10Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, Berlin, Germany
11JSPS Overseas Research Fellow, Japan Society for the Promotion of Science, Tokyo, Japan
12Division of Nephrology, Duke University School of Medicine, Durham, NC, USA
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
© 2021 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society.
Johannes Kovarik, Norihiko Morisawa, Johannes Wild and Kento Kitada contributed equally to this work.  
Correspondence
Kento Kitada and Jens Titze, Programme 
in Cardiovascular and Metabolic Disorders, 
Duke- NUS Medical School, 8 College 




Public Trust Cardiovascular Research 
Fund; Austrian Science Fund; Mitsukoshi 
Health and Welfare Foundation; Astellas 
Foundation for Research on Metabolic 
Disorders; Duke NUS; Japan Heart 
Foundation; Renal Research Institute; 
Japan Society for the Promotion of 
Science, Grant/Award Number: 19K17889; 
Mochida Memorial Foundation for Medical 
and Pharmaceutical Research; Uehara 
Memorial Foundation; DRL Forschung 
Abstract
Aim: We have reported earlier that a high salt intake triggered an aestivation- like 
natriuretic- ureotelic body water conservation response that lowered muscle mass and 
increased blood pressure. Here, we tested the hypothesis that a similar adaptive water 
conservation response occurs in experimental chronic renal failure.
Methods: In four subsequent experiments in Sprague Dawley rats, we used surgical 
5/6 renal mass reduction (5/6 Nx) to induce chronic renal failure. We studied solute 
and water excretion in 24- hour metabolic cage experiments, chronic blood pressure 
by radiotelemetry, chronic metabolic adjustment in liver and skeletal muscle by me-
tabolomics and selected enzyme activity measurements, body Na+, K+ and water by 
dry ashing, and acute transepidermal water loss in conjunction with skin blood flow 
and intra- arterial blood pressure.
Results: 5/6 Nx rats were polyuric, because their kidneys could not sufficiently 
concentrate the urine. Physiological adaptation to this renal water loss included 
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1 |  INTRODUCTION
Perturbations in salt- and- water homeostasis have been impli-
cated in the pathogenesis of arterial hypertension. The intimate 
relationship between body fluid and blood pressure level is 
frequently explained by a physiological feedback- loop model 
in which an underlying inability of the kidneys to completely 
excrete surplus dietary salt and water would causally elevate 
body Na+ and fluid content.1,2 Expanding on this concept, the 
pressure- natriuresis theory suggests that any chronic elevation 
in blood pressure is aimed to improve the excretion of Na+ and 
water by the kidney, suggesting that hypertension is an adaptive 
physiological body response that is designed to prevent a chron-
ically increased body Na+ and fluid content.3- 5
Studying day- to- day changes in blood pressure in rela-
tion to 24- hour solute and water excretion during long- term 
balance experiments in humans, we have found that signifi-
cant spontaneous- rhythmical fluctuations in body Na+ con-
tent occurred without parallel changes in blood pressure.6 
Furthermore, we have reported that increasing salt intake 
in humans and mice triggered a systemic body water con-
servation response to overcome the osmotic- diuretic effect 
of increased urinary salt excretion, which shows surprising 
similarities to aestivation metabolism in amphibians in fish 
during physiological adaptation to water shortage.7,8 Because 
these findings are antipodal to current textbook teaching 
on the pathogenesis of arterial hypertension, we tested our 
alternative view on the relationship between salt and water 
homeostasis and blood pressure in rats with chronic renal 
failure. We hypothesized that an inability to concentrate the 
urine would induce these evolutionary- conserved extrarenal 
water conservation patterns in rats with experimental renal 
mass reduction.
We show that chronic renal failure leads to renal water 
loss, which triggers an extrarenal compensatory body re-
sponse to successfully prevent dehydration. Understanding 
that the animals activate an aestivation- like systemic meta-
bolic and circulatory body response designed to prevent de-
hydration not only explains their “renal” hypertension, but 
also why muscle mass loss occurs in chronic renal failure.
2 |  RESULTS
2.1 | Experimental renal mass reduction 
leads to renal water loss
In a 24- hour metabolic cage experiment, we first tested the 
hypothesis that 5/6 reduction of renal mass (5/6 Nx) in rats 
led to reduced renal solute or water excretion (Table 1). We 
found that neither food intake, which represents solute in-
take, nor urine solute excretion, was different between con-
trol and 5/6 Nx rats. We interpret this finding to show intact 
solute excretion in 5/6 Nx rats, despite significant renal mass 
reduction.
We next studied urine concentration in 5/6 Nx rats. Renal 
mass ablation resulted in a 50% reduction in urine osmolality, 
and increased the urine free- water excretion by 33.9 mL/kg/d, 
which corresponded well to the observed 30.5 mL/kg/d in-
crease in urine volume formation (Table 1). The change in the 
rats’ urine osmolality was almost entirely explained by the 
reduction of the Na+, K+, urea, and accompanying anion con-
centrations in the urine (Figure 1A). The major urine solute 
was urea (Figure 1B), followed by K+ (with accompanying 
anions) and Na+ (with accompanying anions). Renal mass re-
duction did not change the relative contribution of urea, K+ 
unter Weltraumbedingungen, Grant/Award 
Number: 50WB2024; National Heart, 
Lung, and Blood Institute, Grant/Award 
Number: RO1 HL118579
mobilization of nitrogen and energy from muscle for organic osmolyte production, 
elevated norepinephrine and copeptin levels with reduced skin blood flow, which 
by means of compensation reduced their transepidermal water loss. This complex 
physiologic- metabolic adjustment across multiple organs allowed the rats to stabilize 
their body water content despite persisting renal water loss, albeit at the expense of 
hypertension and catabolic mobilization of muscle protein.
Conclusion: Physiological adaptation to body water loss, termed aestivation, is an 
evolutionary conserved survival strategy and an under- studied research area in medi-
cal physiology, which besides hypertension and muscle mass loss in chronic renal 
failure may explain many otherwise unexplainable phenomena in medicine.
K E Y W O R D S
aestivation, body sodium, body water, dehydration, double- barrier concept, glucose- alanine- 
shuttle, glycine methylation, hepato- renal, hypertension, kidney, liver, muscle mass loss, organic 
osmolytes, purine metabolism, skin, transamination, transepidermal water loss, urea cycle, urine 
concentration
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or Na+ solutes to solute excretion or solute concentration in 
the urine.
Compared to their healthy controls, 5/6 Nx rats increased 
their urine volume by 101%, and their fluid intake by 78% 
(Table 1). We hypothesized that renal mass reduction led to 
a urine concentration deficit with polyuria, which triggered 
increased fluid intake to prevent dehydration (Figure  1C, 
primary polyuria). The alternative hypothesis, however, 
was that 5/6 Nx rats might have primarily increased their 
fluid intake, and therefore had subsequently increased their 
urine volume (Figure 1D, primary polydipsia). We therefore 
next analysed their blood plasma and found that, despite in-
creased fluid intake, 5/6 Nx led to an increase in plasma 
osmolality (Table 1), indicating a body water conservation 
response to prevent dehydration. Approximately 79% of this 
water conservation response was explained by an increase 
in plasma urea concentration, and another 20% of the in-
crease in plasma osmolality was explained by elevated con-
centration of the plasma K+ solutes and their accompanying 
anions (Table  1). Plasma Na+ solutes with accompanying 
anions did not contribute to the measured change in plasma 
osmolality (Table 1).
We interpret these findings to show that renal- mass ab-
lation caused an inability to concentrate the urine, and that 
the resulting polyuria predisposed the rats to body water loss.
2.2 | Experimental renal mass reduction 
leads to arterial hypertension, and to tissue 
solute and water accumulation
Chronic renal failure is believed to reduce renal solute and 
water excretion, resulting in body solute and water accumu-
lation, and thereby increasing blood pressure. We therefore 
studied the relationship between blood pressure, urine solute 
and water excretion, and tissue Na+, K+ and water content in 
our rats.
Compared to healthy controls, renal mass ablation 
increased mean arterial blood pressure (101  ±  10 vs 
121 ± 12 mmHg; P < .01). Within the 5/6 Nx animal group, 
blood pressure steeply increased with reduced urine con-
centration (Figure 2A). Their arterial hypertension therefore 
occurred with increased urine volume (Figure 2B); however, 
we could not find a similarly significant relationship between 
T A B L E  1  24- h urine solute excretion, urine solute concentration, plasma solute concentration and water balance in control rats and in rats with 
5/6 renal mass reduction (5/6 Nx)
Control (n = 6) 5/6 Nx (n = 12) P value
24- h Food Intake and Solute Excretion
Food Intake (g/kg/d) 50.1 ± 4.8 54.0 ± 7.0 .243
UNaV (mmol/kg/d) 3.7 ± 0.4 3.6 ± 1.0 .748
UKV (mmol/kg/d) 8.8 ± 1.2 9.2 ± 1.4 .584
UUreaV (mmol/kg/d) 40.9 ± 4.9 40.0 ± 11.8 .867
24- h Water Intake, Urine Volume and Water Balance Gap
Water Intake (mL/kg/d) 67.6 ± 2.9 120.1 ± 20.4 <.001
Urine Volume (mL/kg/d) 30.2 ± 3.8 60.7 ± 15.1 <.001
Water Balance Gap (mL/kg/d) 37.0 ± 3.1 60.0 ± 12.6 <.01
Δ Body Weight (g) −4.7 ± 2.9 −7.3 ± 9.5 .529
24- h Urine Solute Concentration and Free Water Clearance
Urine [Na+] (mmol/L) 124.7 ± 23.4 59.3 ± 12.2 <.001
Urine [K+] (mmol/L) 292.7 ± 29.2 156.9 ± 25.8 <.001
Urine [Urea] (mmol/L) 1372 ± 234 677 ± 184 <.001
Urine Osmolality (mOsm/kg) 2004 ± 249 1009 ± 143 <.001
Free Water Clearance (mL/kg/d) −188.4 ± 23.3 −154.5 ± 30.9 <.05
Plasma Solute Concentrations and Plasma Osmolality
Plasma [Na+] (mmol/L) 138.9 ± 1.8 138.8 ± 2.0 .912
Plasma [K+] (mmol/L) 6.6 ± 0.5 7.3 ± 0.7 <.05
Plasma [Urea] (mmol/L) 4.1 ± 0.8 9.7 ± 1.6 <.001
Plasma Osmolality (mOsm/kg) 282 ± 7 289 ± 4 <.05
Note: Data are expressed as average ± SD.
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urine volume and blood pressure solely within the 5/6 Nx 
group.
We next studied changes in body solute and water content 
in our rats by chemical analysis (Table 2). Except for a small 
reduction in absolute Na+ content in the skinned carcass, ab-
solute Na+, K+ and water content in rats with renal mass re-
duction was not different from their healthy controls, neither at 
the total body level, nor in their skin or in the skinned carcass. 
However, 5/6 Nx rats showed reduced tissue dry weight, indi-
cating catabolism with stunted growth. 5/6 Nx rats therefore 
increased their tissue Na+, K+, and water content per tissue 
mass (Figure S1). Analysis of the tissue solute- to- water ratio 
showed total body and tissue [Na+ + K+] concentrations that 
were consistently higher than their plasma [Na+ + K+] concen-
trations. This concentration difference persisted in skin tissue, 
which is bone- and cartilage- free. In the skin, an increase in 
F I G U R E  1  Chronic renal failure leads to renal water loss. A, Contribution of 24- h urine Na+, K+ and urea solute concentration to urine 
osmolality (UOsm) in control rats (n = 6) and in rats with 5/6 renal mass reduction (5/6 Nx; n = 12). Note that Na+ and K+ excretion are calculated 
twofold to account for the excretion of unmeasured accompanying anions. B, Relative contribution of Na+, K+ and urea solutes to urine solute 
formation in the same rats. Data expressed as average ± SD. C, Relationship between urine osmolality and urine volume in the same rats. D, 
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F I G U R E  2  Relationship between renal 
water loss, tissue water content, and blood 
pressure. A, Relationship between urine 
osmolality and mean arterial blood pressure 
(MAP). B, Relationship between urine 
volume and blood pressure. C, Relationship 
between absolute Na++ K+ and absolute 
water content in the skin. ( ): we excluded 
the data points with lowest and with highest 
Na++ K+ content from regression analysis. 
D, Relationship between skin Na++ K+ 
content per gram dry skin and mean arterial 
blood pressure. Data are from the same rats 
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Na+ + K+ solutes of 2 mmol was paralleled by an 11 mL in-
crease in water content, resulting in a skin tissue [Na+ + K+] 
solute concentration of ≈181 mmol/L (Figure 2C). The result-
ing accumulation of Na+ and K+ per skin tissue mass in 5/6 Nx 
rats (Table 2), which was paralleled by less fluid accumulation 
than predicted by the theory of isotonic body fluid distribution 
(Table 2 and Figure 2C), was associated with increased blood 
pressure (Figure 2D). We found no direct or indirect correla-
tion between skin tissue Na+ and K+ overload and blood pres-
sure in the 5/6 Nx animal group alone (Figure 2D).
We interpret these findings to show that the arterial 
hypertension that occurred in 5/6 Nx rats, together with 
T A B L E  2  Chemical analysis of Na+, K+ and water content in total body, skin and skinned rest carcass from the same rats as reported in 
Table 1
Control (n = 6) 5/6 Nx (n = 12) P value
Total body (TB) Na+, K+ and water content and concentrations
TB Wet Weight (g) 274.2 ± 11.1 264.7 ± 21.3 .326
TB Dry Weight (g) 92.6 ± 4.6 85.4 ± 6.9 <.05
TB Na+ Content (mmol) 14.59 ± 0.61 14.12 ± 0.77 .212
rTB Na+ Content (mmol/g DW) 0.158 ± 0.007 0.166 ± 0.006 <.05
TB K+ Content (mmol) 23.47 ± 0.66 22.92 ± 1.69 .454
rTB K+ Content (mmol/g DW) 0.254 ± 0.011 0.269 ± 0.014 <.05
TB Water Content (mL) 181.6 ± 6.7 179.3 ± 15.0 .730
rTB Water Content (mL/g DW) 1.963 ± 0.036 2.102 ± 0.086 <.01
TB Na+ / Water Ratio (mmol/mL) 0.080 ± 0.003 0.079 ± 0.004 .432
TB K+ / Water Ratio (mmol/mL) 0.129 ± 0.005 0.128 ± 0.008 .732
TB (Na+ + K+) / Water Ratio (mmol/mL) 0.210 ± 0.007 0.207 ± 0.010 .576
Skinned rest carcass (Car) Na+, K+ and water content and concentrations
Car Wet Weight (g) 210.2 ± 9.2 203.4 ± 14.9 .323
Car Dry Weight (g) 66.7 ± 3.1 61.7 ± 4.2 <.05
Car Na+ Content (mmol) 10.55 ± 0.29 10.08 ± 0.41 <.05
rCar Na+ Content (mmol/g DW) 0.159 ± 0.007 0.164 ± 0.008 .186
Car K+ Content (mmol) 20.58 ± 0.65 19.93 ± 1.54 .342
rCar K+ Content (mmol/g DW) 0.309 ± 0.019 0.323 ± 0.019 .153
Car Water Content (mL) 143.6 ± 6.5 141.7 ± 11.1 .712
rCar Water Content (mL/g DW) 2.154 ± 0.055 2.296 ± 0.087 <.01
Car Na+ / Water Ratio (mmol/mL) 0.074 ± 0.003 0.071 ± 0.004 .268
Car K+ / Water Ratio (mmol/mL) 0.144 ± 0.007 0.141 ± 0.010 .574
Car (Na+ + K+) / Water Ratio (mmol/mL) 0.217 ± 0.009 0.212 ± 0.012 .408
Skin (SK) Na+, K+, and water content and concentrations
SK Wet Weight (g) 63.9 ± 6.6 61.3 ± 7.1 0.453
SK Dry Weight (g) 25.9 ± 2.8 23.6 ± 2.9 0.136
SK Na+ Content (mmol) 4.09 ± 0.44 4.04 ± 0.50 0.986
rSK Na+ Content (mmol/g DW) 0.156 ± 0.007 0.171 ± 0.011 <0.01
SK K+ Content (mmol) 2.89 ± 0.31 2.99 ± 0.37 0.609
rSK K+ Content (mmol/g DW) 0.112 ± 0.010 0.127 ± 0.013 <0.05
SK Water Content (mL/g DW) 38.0 ± 4.1 37.6 ± 4.6 0.852
rSK Water Content (mL/g DW) 1.471 ± 0.100 1.595 ± 0.134 0.061
SK Na+ / Water Ratio (mmol/mL) 0.106 ± 0.006 0.108 ± 0.010 0.708
SK K+ / Water Ratio (mmol/mL) 0.077 ± 0.008 0.080 ± 0.012 0.497
SK (Na+ + K+) / Water Ratio (mmol/mL) 0.183 ± 0.012 0.188 ± 0.021 0.567
Note: Data are expressed as average ± SD. Total body parameters are the sum of rest carcass and skin parameters.
Abbreviations: DW, dry weight; r, solute and water content normalized to dry tissue mass.
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increased fluid intake and tissue solute accumulation, was 
likely part of a systemic body response that was designed 
to prevent dehydration. We hypothesized that physiologi-
cal adaptation to water shortage, termed aestivation, might 
stabilize body water content during states of chronic renal 
water loss. We therefore next tested the hypothesis that the 
renal water loss had triggered a systemic extrarenal met-
abolic aestivation- like water conservation response in 5/6 
Nx rats.
2.3 | Extrarenal water conservation motif 
1: urea cycle activation and exploitation of 
energy and nitrogen stored in skeletal muscle
The increase in plasma urea concentration in 5/6 Nx rats, 
which occurred without a parallel increase in plasma Na+ 
concentration and in the absence of reduced renal urea 
excretion (Table 1), suggests that renal fluid loss in chronic 
renal failure may have triggered a compensatory hepatic aes-
tivation response. To test this hypothesis, we conducted a 
second independent experiment, in which we first confirmed 
the water- losing renal phenotype in 5/6 Nx rats (Figure S2), 
and then studied the nitrogen- dependent metabolic pathways 
of organic osmolyte production.
2.3.1 | Urea cycle activation
Urea production in the liver requires nitrogen transfer from amino 
acids to glutamate, and nitrogen transfer as NH4
+ for carbamoyl 
phosphate (CP) synthesis (Figure  3A). We found increased 
hepatic amino acid levels, increased α- ketoglutaramate levels 
(α- KGM), which is an indicator of hepatic NH4
+ overload9; in-
creased N- acetyl- glutamate levels (NAG), which is the allosteric 
effector that activates CP enzyme activity10; elevated arginase 
F I G U R E  3  Chronic renal failure leads to reprioritization of liver and muscle nitrogen metabolism for water conservation. A, Metabolomic 
analysis of differences in nitrogen utilization for urea osmolyte production, urate production, creatine and NO production and nitrogen transfer from 
the muscle branched- chain amino acids (BCAA) and muscle dipeptides, carnosine and anserine, between control (n = 6) and 5/6 Nx (n = 10) rats. 
Key enzymes for urea generation are arginase (#1), cytoplasmatic malate dehydrogenase 1 (MDH1; #2), and aspartate aminotransferase (ASAT; 
#3). B, Arginase activity in control (n = 6) and 5/6 Nx rats (n = 10). C, Malate dehydrogenase 1 (MDH1) activity in the same rats. D, Aspartate 
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enzyme activity (the rate- limiting enzyme for nitrogen transfer 
from arginine into urea; Figure 3B), and increased hepatic urea 
content in 5/6 Nx rats. We interpret these findings to show that 
renal water loss in rats with chronic renal failure triggered the 
aestivation motif of increased urea osmolyte production and ac-
cumulation, in an effort to stabilize body water content.
2.3.2 | Origin of the nitrogen used for 
urea synthesis
Because we found no evidence of increased food intake in 
5/6 Nx rats and thus concluded that protein intake was similar 
between the groups (Table 1), we next tested the hypothesis 
that the urea cycle activation was coupled with endogenous 
protein exploitation. Besides CP synthesis from HCO3
-  and 
NH4
+, nitrogen transfer into the urea cycle relies on the gen-
eration of the carbonic acid oxaloacetate (Oa) from malate 
(Mal), catalysed by the cytoplasmatic form of the enzyme 
malate dehydrogenase (MDH1; Figure  3A,C), followed by 
transamination of oxaloacetate to aspartate. This transami-
nation step is catalysed by the cytoplasmatic enzyme as-
partate aminotransferase (ASAT; Figure  3A,D). We found 
that 5/6 Nx rats increased transfer of nitrogen into the urea 
cycle by promoting cytoplasmatic oxaloacetate generation 
via increased MDH1 activity (Figure 3C), and by promoting 
carbonic acid transamination via increased ASAT activity 
(Figure 3D).
The carbonic acids α- keto- β- methylvalerate (KMV), α- 
keto- isocaproate (KIC), and α- keto- isovalerate (KIV) are 
generated by the catabolism of the branched chain amino 
acids (BCAA) isoleucine (ILeu), leucine (Leu) and valine 
(Val; Figure 3A). The catabolism of the BCAAs11 is initiated 
by transfer of their nitrogen group to the carbonic acids py-
ruvate (Pyr) to form alanine (Ala), oxaloacetate (Ox) to form 
aspartate (Ast), or α- ketoglutarate (α- KG) to form glutamate 
(Glu) by transamination (Figure 3A). Rats with experimental 
renal mass reduction showed decreased valine, KMV, KIC 
and KIV levels in conjunction with elevated intermediates of 
BCAA catabolism, including their ketogenic intermediate, β- 
hydroxybutyrate (BHB; Figure 3A). To better understand the 
origin of increased BHB in muscle, we in parallel examined 
ketone production in the liver. We found no signs of increased 
hepatic ketone body production in 5/6 Nx rats (Figure 3A), 
indicating that the increased β- hydroxybutyrate levels in skel-
etal muscle most likely resulted from exploitation of muscle 
protein with BCAA catabolism.
Anserine and carnosine are dipeptides that contain 
1- methylhistidine (1- MeH) or histidine (His) together with 
β- alanine (β- Ala), which is not integrated into the muscle 
protein matrix. The two dipeptides can therefore be viewed 
as dedicated metabolic muscle energy and nitrogen reservoirs 
that can be rapidly mobilized without reducing muscle fibre 
mass.12 We found reduced levels of both peptides in the skel-
etal muscle of 5/6 Nx rats. The exploitation of the anserine 
and carnosine muscle reservoir was paralleled by increased 
histidine and 1- methylhistidine levels.
We interpret these findings to show that 5/6 Nx rats with 
renal water loss exploited their muscle BCAAs as well as 
their anserine and carnosine stores to support hepatic urea 
osmolyte production in an effort to stabilize their body water 
content.
2.4 | Extrarenal water conservation 
motif 2: experimental renal mass reduction 
promotes organic osmolyte production by 
glycine methylation
The methylation of glycine (Gly) generates three impor-
tant organic osmolytes that stabilize intracellular fluid 
content: 1- methyl- glycine, termed sarcosine (Sarc); 
2- methyl- glycine (DMG), and 3- methyl- glycine, termed 
betaine (Figure 4A). Furthermore, cells can actively syn-
thesize the glycine by tetrahydrofolate (THF)- dependent 
methylation of serine (Ser). We found elevated serine, 
glycine, and betaine levels in the liver of 5/6 Nx rats 
(Figure 4A), indicating increased hepatic glycine methyla-
tion for organic osmolyte generation.
2.4.1 | Metabolic glycine retention
Successful betaine synthesis requires glycine as a substrate. 
Alternatively, glycine serves as a substrate for hepatic creatine 
generation. Catalysed by the enzyme arginine:guanidinoacetate 
amidino transferase, liver reversibly transfers an amidino 
(CH4N2) group from arginine (Arg) to glycine, resulting in 
guanidino acetate and ornithine (Orn) generation (Figure 4A). 
Catalysed by the enzyme guanidino acetate methyl transferase 
(GAMT), liver then methylates guanidino acetate to creatine 
(Figure 4A). Our 5/6 Nx rats showed decreased GAMT en-
zyme activity (Figure 4B) and reduced hepatic creatine levels, 
while their guanidino acetate, ornithine, glycine, arginine lev-
els were elevated (Figure 4A), and their arginase- driven urea 
synthesis was promoted (Figure 3B). We interpret these find-
ings to show that 5/6 Nx rats reprioritized their hepatic arginine 
metabolism in favour of nitrogen transfer into urea osmolyte 
production, but enzymatically inhibited the alternative transfer 
of arginine- derived amidino groups to creatine by reducing the 
rate of creatine production from guanidino acetate. Since ami-
dino transfer from arginine to glycine is bidirectional, reduced 
GAMT enzyme activity thereby supported the availability of 
glycine as a substrate for betaine synthesis in 5/6 Nx rats.
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2.4.2 | Glycine methylation
The enzymatic S- adenosyl- methionine (S- Ado- Met) / S- 
adenosyl- homocysteine (S- Ado- Hcys) methylation system 
transfers a methyl group from methionine to glycine, sarcosine, 
and dimethyl- glycine to ultimately form betaine (Figure 4A). 
Organic osmolyte production by methylation of amino acids 
is intimately coupled with purine metabolism (Figure  4A). 
Adenyloscuccinate (AdenyloSucc) biosynthesis for AMP/
ATP generation requires glycine, glutamine, and aspartate to 
form inosine monophosphate (IMP) from 5- phosporibosyl py-
rophosphate (PRPP). Aspartate not only donates the N- 1 atom 
to the IMP purine ring, but also donates the – NH2 group in 
the adenylosuccinate synthetase reaction that forms adenylo- 
succincate from IMP. This reaction in turn releases the citric 
acid cycle intermediate fumarate, which, catalysed by cyto-
solic MDH- 1 and ASAT, forms a cytoplasmatic purine nucle-
otide cycle for sustainable adenylosuccinate/AMP production 
(Figure 4A). The increased MDH- 1 and ASAT enzyme activity 
we observed in 5/6 Nx rats (Figure 3C,D) therefore not only 
supported urea osmolyte synthesis (Figure 3A), but also paral-
lel purine biosynthesis (Figure 4A).
Besides increased nitrogen- and energy- intense nucle-
otide generation, the retention of nucleotides in tissue can 
be viewed as an additional energy- efficient way to support 
the methylation machinery for organic osmolyte production. 
Uricotelic animals, such as reptiles, birds and insects, utilize 
uric acid for NH4
+ elimination instead of urea. Our ureotelic 
5/6 Nx rats with chronic renal water loss showed a differ-
ent metabolic response (Figure 4A). Despite elevated hepatic 
AMP and elevated GMP/Guanosine levels, we found reduced 
inosine, xanthine and urate levels in the livers of 5/6 Nx rats, 
suggesting reduced xanthine oxidase- mediated generation of 
urate. The rats with chronic renal failure thus metabolically 
promoted the nitrogen transfer necessary for nucleotide gen-
eration, and in parallel reduced hepatic elimination of nitrog-
enous waste from purine catabolism, resulting in elevated 
hepatic AMP levels.
F I G U R E  4  Reprioritization of purine and nitrogen metabolism in favour of methylamine production in rats with chronic renal failure. A, 
Metabolomic analysis of purine nitrogen and glycine utilization for betaine osmolyte production in the same rats as reported in Figure 3. The 
biosynthesis of S- adenosyl- methionine (SAM) in 5/6 Nx rats, which is responsible for the methylation of glycine during betaine synthesis, is 
promoted by the cataplerotic enzymes MDH1 (#2) and aspartate aminotransferase (#3) in the purine nucleotide cycle. Parallel increases in arginase 
activity (#1), in conjunction with reduced activity of guanidino- acetate methyl transferase (GAMT; #4), reduces nitrogen transfer from arginine 
to creatine, and increases the availability of glycine as a substrate for organic osmolyte production. B, Densitometric quantification of guanidino- 
acetate methyl transferase (GAMT) protein levels in liver and muscle of six control and six rats with 5/6 Nx. C, Densitometric quantification of 
the ratio of the phosphorylated and unphosphorylated for AMP- activated kinase (AMPK) in the same rats. D, Densitometric quantification of 
phosphorylated acetyl- CoA carboxylase (p- ACC) protein levels in the same rats. E, Western Blots of AMPK, pAMPK, pACC and GAMT protein 
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An alternative explanation for the elevated AMP lev-
els, however, is energy deficit, which lowers ATP levels 
and thereby increases tissue AMP content. We therefore 
next analysed the protein expression levels of the cellu-
lar energy level sensor, AMP- kinase (AMPK). Despite 
elevated AMP levels, we found no increase in the ratio 
between phosphorylated and unphosphorylated AMPK in 
5/6 Nx rats (Figure 4C), while the protein levels of phos-
phorylated acetyl- CoA- carboxylase (Figure  4D,E) were 
reduced. This finding suggests that 5/6 Nx rats reduced 
triglyceride synthesis and thereby shifted metabolism to-
wards the observed exploitation of endogenous fat stores 
(Figure 3A), and that this metabolic fuel switch was suffi-
cient to prevent energy- deficiency with increased AMPK 
and p- AMPK levels.
We interpret these findings to show that the body water 
conservation response in 5/6 Nx rats included preferential 
nitrogen transfer from arginine into urea solute production, 
which is coupled with reduced nitrogen transfer into cre-
atine to promote glycine substrate accumulation for organic 
osmolyte production by glycine methylation. Reduction of 
hepatic uric acid synthesis additionally predisposes to pu-
rine retention, which supports the S- adenosine- methionine/
homocysteine methylation machinery for organic osmolyte 
generation.
2.5 | Extrarenal water conservation 
motif 3: experimental renal mass reduction 
promotes cutaneous vasoconstriction to reduce 
transepidermal water loss
We finally studied the relationship between extrarenal water 
conservation, vasoconstriction and blood pressure level in our 
rats. Arterial hypertension is invariably coupled with an in-
crease in peripheral vascular resistance. We found four impor-
tant reasons why peripheral vascular resistance was increased in 
5/6 Nx rats. First, metabolomic analysis showed increased lev-
els of asymmetric and symmetric dimethyl- arginine (ADMA; 
SDMA) and mono- methyl- arginine (MMA) in 5/6 Nx rats 
(Figure 3A). We interpret this finding to show that 5/6 Nx rats 
with activated methylation machinery not only generated more 
betaine from glycine (Figure 4), but also increased the meth-
ylation of arginine. The increased generation of the potent en-
dothelial nitric oxide (NO) synthase inhibitors, MMA, ADMA 
and SDMA, results in reduced vascular NO production and 
increases vascular tone. Second, we found increased levels of 
γ- glutamyl- aminoacids (γ- glutamyl- AA), cysteine- glutathione 
disulfide (GSH- ss- Cys), α- hydroxybutyrate (α- HB) in 5/6 Nx 
rats (Figure 3A), suggesting oxidative stress with endothelial 
dysfunction. Third, we found a 14- fold increase in plasma co-
peptin levels in 5/6 Nx rats (Figure 5A), indicating increased 
F I G U R E  5  Rats with chronic renal failure reduce cutaneous blood flow to limit transepidermal water loss, albeit at the expense of 
arterial hypertension. A, Plasma copeptin and skin angiotensin II (Ang II) levels in the same rats as described in Figures 1 and 2. B, 24- h urine 
norepinephrine (NE) excretion and plasma Ang 2 levels in control (n = 10) and 5/6 Nx rats (n = 14), in which we in parallel measured their plasma 
Ang 2 levels (controls: n = 7; 5/6 Nx: n = 12). C, Time- dependent increase in body core temperature in anaesthetized control (n = 3) and 5/6 Nx 
rats (n = 3) exposed to 33°C ambient temperature; and D, Changes in intra- arterial mean arterial blood pressure (MAP) in response to increasing 
body temperature. E, Cutaneous blood volume in response to increasing body core temperature in control (n = 5) and 5/6 Nx (n = 6) rats. F, 
Transepidermal water loss (TEWL) in response to increasing body core temperature in the same rats as in (E). G, Relationship between skin blood 
volume and TEWL in the same rats as in (E and F). Data are expressed as average ± SD and analysed by multivariate or univariate General Linear 
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antidiuretic hormone (ADH; vasopressin) action. Fourth, we 
found increased 24- hour norepinephrine excretion (NE) in the 
urine of 5/6 Nx rats (Figure 5B), indicating increased sympa-
thetic nerve tone. Only the peptide levels of the strong vaso-
constrictor angiotensin II (Ang 2) were not different between 
control and 5/6 Nx rats, neither in skin tissue (Figure 5A), nor 
in plasma (Figure 5B).
Redistribution of blood volume and regulation of skin 
blood flow are closely related to the release of thermic en-
ergy and water across the skin. Vasodilation and the open-
ing of arterio- venous shunts translocate a relevant fraction 
of the total body blood volume from more central areas of 
the circulation into the vascular counter current system of the 
skin. The more blood is transferred from the body core to 
the surface of the skin, the more heat transfer can occur to 
prevent increasing core temperature during exercise and/or 
environmental heat exposure. The resulting heat dissipation 
for maintenance of normal body temperature, however, cou-
ples with an increase in transepidermal water loss.13 During 
thermoregulation, the diameter of cutaneous skin vessels 
is largely controlled by adrenergic norepinephrine- driven 
vasoconstriction.14 This nerve- driven vasoconstrictor tone 
is gradually withdrawn with increasing body temperature, 
resulting in vasodilation of cutaneous blood vessels for im-
proved heat dissipation, which lowers blood pressure,15 albeit 
at the expense of increased transepidermal water loss.
We thus hypothesised that physiological adaptation to 
renal water loss in 5/6 Nx rats might include vasoconstriction 
of cutaneous blood vessels in an effort to reduce the cutane-
ous blood volume, which in turn would reduce the animals' 
transepithelial water loss for body water conservation, albeit 
at the expense of increased peripheral resistance and ele-
vated blood pressure. We tested this hypothesis in additional 
experiments in anaesthetized rats in which we monitored 
blood pressure via an arterial line and increased their body 
temperature by exposing them to 33°C ambient temperature 
(Figure 5C- G). Heat exposure increased body core tempera-
ture in both control and 5/6 Nx rats (Figure 5C). However, 
with an increase in body temperature above 36.5°C, blood 
pressure in anaesthetized 5/6 Nx rats rapidly fell to the control 
level (Figure 5D). This finding suggests that with increasing 
body temperature, pre- existing cutaneous vasoconstriction in 
5/6 Nx rats ceased to allow for improved dermal heat dissi-
pation, and that the opening of skin vessels for improved heat 
transfer was sufficient to reduce blood pressure back to the 
control level.
We therefore next tested the hypothesis that 5/6 Nx rats 
showed reduced cutaneous blood pooling and lower transepi-
dermal water loss, which would cease with increasing body 
core temperature. Rats with chronic renal failure at 35⁰C 
body temperature showed lower skin blood volume than 
controls, which increased back to the higher control level 
with increasing body temperature at 36⁰C- 37⁰C (Figure 5E). 
With lower skin blood volume than controls, 5/6 Nx rats 
showed the expected reduction in transepidermal water loss 
(TEWL; Figure  5F), which increased back to the control 
level once the skin blood volume was increased with higher 
body temperature. The body temperature- driven reopening 
of skin vessels with its surrogate marker of increased skin 
blood volume abolished the cutaneous water conservation 
response in 5/6 Nx rats (Figure 5G). Rats with chronic renal 
failure additionally showed a tendency towards higher skin 
blood flow velocity, which was not modulated by changes 
in body temperature (Figure  S3A). Therefore, 5/6 Nx rats 
showed no direct relationship between skin blood flow ve-
locity and the observed body temperature- driven changes in 
TEWL (Figure S3B). The detectable increase in cutaneous 
blood flow that occurred with increasing body temperature in 
5/6 Nx rats (Figure S3C), which was paralleled by increased 
TEWL (Figure S3D), was mainly attributable to the normal-
ization of cutaneous blood pooling with increasing body tem-
perature (Figure 5E).
We interpret these findings to show that 5/6 Nx rats re-
duced cutaneous blood flow and thereby limited their tran-
sepidermal water loss in an effort to compensate for their 
renal water loss. This adaptive physiological dermal water 
conservation response was reversible once 5/6 Nx rats ad-
ditionally translocated more blood volume from the central 
circulation to the skin surface for body heat dissipation. The 
observation that the reversal of this transepidermal water 
conservation response, which requires dilation of cutaneous 
skin vessels, was paralleled by a normalization of blood pres-
sure suggests that cutaneous vasoconstriction may be an im-
portant causal pathophysiological factor in the development 
of renal hypertension.
3 |  DISCUSSION
Studying urine solute and water excretion in conjunction 
with body solute content, water content and telemetric blood 
pressure recording, we report three findings that are antipodal 
to established thinking in medical salt and water physiology 
and hypertension- related research.
First, we found that our rats with chronic renal failure 
excreted the appropriate amount of Na+, K+ and urea sol-
utes in their urine, and they instead had to adjust to renal 
water loss because of an inability to concentrate their urine. 
Our data confirm an earlier report demonstrating that surgi-
cal 5/6 renal mass ablation leads to renal water loss without 
commensurate increases in 24- hour Na+ and K+ solute ex-
cretion.16 These findings are antipodal to the idea that exper-
imental chronic renal failure results in an inability to excrete 
sufficient amounts of Na+, K+, urea and water.
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Second, we found that the rats’ body response to this de-
hydration stress was characterized by a primarily urea- driven 
increase in plasma osmolality and the accumulation of Na+, 
K+, urea and other organic osmolytes in the tissues. In line 
with our previous studies,17- 20 but not in line with a recent 
study analysing small tissue samples in WKY and sponta-
neously hypertensive rats,21 we found that the (Na++K+)- 
to- water ratio in the rat skin is substantially higher than the 
[Na++K+] concentration in plasma. This result is expected,22 
because the keratinocyte layer generates a regional microen-
vironment with high Na+ and K+ concentration,23- 30 which 
is non- invasively detectable in- vivo in humans with ultra- 
high field 23NaMRI.31 Our simple chemical analysis cannot 
address the question whether these local cutaneous concen-
tration gradients were altered in 5/6 Nx rats. The observed ac-
cumulation of Na+, K+ and water per unit tissue mass in 5/6 
Nx rats occurred at constant absolute skin Na+ and K+ con-
tent because of a reduction in skin tissue mass, and therefore 
could not have been detected even in most accurate salt and 
water balance studies.32 The observed changes in tissue solute 
and water composition and plasma osmolality occurred in the 
absence of any change in plasma Na+ concentration. These 
findings are antithetical to the idea that body solute and water 
physiology follows a simple passive equilibrium, in which 
the pattern of renal solute and water excretion would easily 
predict the changes in body solute and water composition.
Third, we found that the blood pressure level in 5/6 Nx 
was directly related to the degree of their renal urine con-
centration deficit, which resulted in higher urine volumes 
and predisposed the animals to dehydration. This finding 
suggests that the cause of the rats’ arterial hypertension 
develops in the context of an adaptive physiological body 
response designed to prevent dehydration. This conclusion 
is antithetical to the concept that the pathophysiological 
cause of arterial hypertension originates from a body re-
sponse that is designed to prevent body Na+ and water 
overload during states of reduced renal Na+ and water ex-
cretion.3 This theory is not easily applicable to explain the 
hypertension in our 5/6 Nx rats, because it is difficult to 
hypothesize that an organism that requires adaptive physi-
ological water conservation to prevent dehydration would 
utilize physiological adaptive pressure natriuresis which 
would even further worsen renal water loss (Figure  S4). 
Furthermore, our data suggest that compensatory vasocon-
striction in an effort to limit further water loss across intact 
biological barriers may functionally explain the observed 
hypertension in 5/6 Nx rats, because successful stabiliza-
tion of body water content at the expense of higher vascu-
lar tone will inevitably increase systemic blood pressure 
levels. We suggest that the resulting hypertension was 
rather an adverse side effect of successful water conserva-
tion by vasoconstriction.
While standard medical physiology literature on the prin-
ciples of body solute and water homeostasis did not allow 
us to interpret these seemingly paradoxical study results, 
our data are in line with an alternative view on the princi-
ples of solute and water physiology that is well- established 
in the zoological sciences. Physiological adaptation to water 
shortage, termed aestivation, is an evolutionary preserved 
physiological- adaptive survival strategy that allowed life to 
move out of the aquatic environments to the arid land.33- 35 
Amphibians that enter brackish water with higher salinity 
than their usual environment experience acute movement of 
water out of their body, predisposing them to dehydration 
stress.36 In an effort to resist body water loss, aestivators pro-
duce and accumulate solutes in their bodies. Aestivators limit 
renal and dermal excretion of urea and thereby increase urea 
levels in tissues and plasma.37 Besides urea, they accumulate 
Na+, Cl-  and other organic osmolytes, such as amino acid de-
rivatives like methylated glycine products in their biological 
barriers. The resulting solute accumulation allows aestivators 
to maintain body hydration in hostile ‘dehydrating’ environ-
ments.36,38- 54 Aestivating lungfish or cartilaginous fishes in 
high- salinity marine environments primarily utilize urea for 
water conservation, without a notable contribution of Na+ 
solutes.55- 58 The perhaps major advantage of such urea- and 
other organic osmolyte- driven water conservation over Na+ 
and K+ solute- driven water conservation is that organic os-
molytes can be generated by exploitation of endogenous fuel 
stores, which makes the physiological- adaptive process of 
body water conservation more autonomous and less reliant 
on dietary environmental factors. Successful water conser-
vation therefore not only requires efficient transporter- driven 
recycling of Na+, K+, urea and other organic osmolyte sol-
utes in the biological barriers of the kidney, gut and skin. 
During dehydration stress body water conservation addition-
ally relies on increased production of intracellular organic os-
molytes.59 De- novo synthesis of urea solutes, which readily 
equilibrate in the extra- and intracellular space, has been the 
most frequently studied dehydration response in aestivators. 
Because organic solute production is both energy intense and 
nitrogen dependent, its increased biosynthesis as a solute for 
water conservation relies on the catabolism of protein.60- 68 
Thus, successful water conservation is paralleled by substan-
tial fuel switches in systemic energy metabolism.7,8
The word ‘aestivation’ derives from the Latin word for 
‘summer’ (aestas) or ‘heat’ (aestus) and describes a series of 
such evolutionarily conserved metabolic switches that allow 
organisms to survive arid conditions with reduced fuel and 
restricted water availability.69- 71 Combining modern metab-
olomics analysis with traditional techniques for clinical in-
vestigation of body fluid homeostasis, we show that these 
key metabolic aestivation principles are not restricted to the 
metabolism of plants, fish, toads, frogs, salamander or other 
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amphibia, but also occur in our mammalian rodent model 
of experimental renal failure. This alternative physiological 
view, seemingly paradoxical at first gance, ultimately pro-
vides with a simple and straightforward explanation for the 
development of sarcopenia and elevated blood pressure in 
chronic renal failure.
First, we find that the “renal uremic phenotype” in chronic 
kidney failure with accumulation of urea, salt, and water in 
the body is not explained by reduced excretion of solutes and 
water by diseased kidneys, but instead is understandable as 
a powerful extrarenal adaptive aestivation response that is 
designed to prevent lethal dehydration by accumulation and 
production of solutes in body tissues. The dependency of the 
underlying water conservation patterns on energy and nitro-
gen transfer for organic osmolyte production explains why 
chronic renal failure will ultimately lead to reduced muscle 
mass (Figure S5).
Second, we find that the “renal hypertension pheno-
type” is difficult to explain by a complicated adaptive body 
response designed to overcome an inability of the kidneys 
to excrete sufficient amounts of salt and water.1- 3,72 Rather, 
the blood pressure increase in our rats with chronic renal 
failure can be understood as an adaptive water conserva-
tion response that utilizes vascular vasoconstriction to 
limit body water loss. The idea that local control of skin 
blood volume and skin blood flow may be a critical com-
ponent for systemic blood pressure regulation in essential 
hypertension is not new,13,15,73- 80 and the importance of 
skin barrier physiology for systemic blood pressure con-
trol has been highlighted in several recent experimental 
studies.15,20,29,73- 75,81,82 Recapitulating this concept in rats 
with chronic renal water loss adds the substantiated hy-
pothesis that cutaneous vasoconstriction might be a rel-
evant component of a multifactorial, systemic, adaptive 
physiological water conservation response which limits 
body water loss across the skin, albeit at the expense of 
arterial hypertension (Figure S5). In line with the concept 
that reduced NO production in keratinocytes may lead to 
cutaneous vasoconstriction and thereby cause essential hy-
pertension,15,73,74,77- 79,82 our metabolomic analysis suggests 
that 5/6 Nx rats systemically reprioritize nitrogen transfer 
from arginine in favour of urea and other organic osmolyte 
solute production for water conservation, while nitrogen 
transfer from arginine to NO is inhibited (Figures  3 and 
4). Furthermore, the increased ADH release as part of the 
body water conservation response in 5/6 Nx rats may not 
only have promoted residual free water reabsorption in their 
remnant 1/6 kidney mass, but is also a strong vasoconstric-
tor which reduces cutaneous blood flow,83- 91 reduces tran-
sepidermal water loss 92- 96 and increases blood pressure.97
However, regulation of skin blood volume and flow 
is dominated by adrenergic norepinephrine- driven vaso-
constriction.14 Edholm et al reported earlier that extant 
vasoconstrictor nerve activity ceases with acute heat stress, 
and cutaneous vasodilation ensues.98 In line with this obser-
vation, the systemic body water conservation response in our 
5/6 Nx rats also included increased norepinephrine excretion 
in the urine, indicating increased sympathetic nerve activity. 
The observed increase in reactive oxygen species genera-
tion (Figure 3A), the reprioritization of arginine metabolism 
with endogenous eNOS inhibition (Figure 3A), and elevated 
ADH levels (Figure 5A) suggest that the renal hypertension 
in 5/6 Nx rats develops with multifactorial generalized va-
soconstriction, which might be difficult to reverse (resis-
tant hypertension). We were surprised to find that despite 
this generalized predisposition to increased vascular tone, 
we found rapid correction of reduced skin blood volume 
(Figure 5E), reduced transepidermal water loss (Figure 5F) 
and elevated blood pressure (Figure 5D) once our 5/6 Nx rats 
needed to dissipate more heat with increasing body tempera-
ture, albeit at the expense of increased transepidermal water 
loss (Figure 5G and Figure S6). This finding suggests that 
modulation of sympathetic/parasympathetic nerve activity 
could acutely override the multifactorial predisposition to 
vasoconstriction once improved heat dissipation was neces-
sary. We hypothesize that any chronic predisposition to de-
hydration will predispose to dermal vasoconstriction, which 
may cause chronic blood pressure elevation. As we did not 
measure blood flow in the other barriers gut, kidney and 
lungs, it remains unclear to which extent the observed water- 
conserving and blood pressure- increasing effect in 5/6 Nx 
rats is explained by selective changes in the skin circulation.
3.1 | Physiological relevance
Despite the fundamental importance of aestivation as a phys-
iological response for body water conservation, its metabolic 
principles are not usually a topic of structured medical educa-
tion. A detailed description of aestivation and its underlying 
regulatory mechanisms can be found elsewhere.34,35,60- 68,99 
We have reported earlier that mice with intact renal func-
tion show comparable aestivation- like water conservation 
patterns to limit Na+- and Cl- - driven osmotic diuresis on 
a high- salt diet.7 It is tempting to speculate that additional 
dietary salt loading in 5/6 Nx rats might augment the renal 
water loss and trigger an even more pronounced extrarenal 
water conservation response with more severe exploitation 
of muscle protein for organic solute generation, more pro-
nounced dermal water conservation, and exaggerated arterial 
hypertension.
Besides the here described disturbance in free water re-
absorption, renal water loss can occur because of osmotic 
diuresis during excess Na+ (with accompanying anions), 
K+ (with accompanying anions), urea or glucose sol-
ute excretion. We hypothesize that all these states will be 
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accompanied by the activation of various aestivation motifs 
for adaptive physiological water conservation. Aestivation 
metabolism is an evolutionary survival strategy that, be-
sides water conservation, induces cellular hypometabolism 
and thereby preserves organ function. Increased urinary 
Na+ and glucose excretion with SGLT2 inhibitor treatment 
likely triggers such adaptive aestivation responses, which 
improve cellular lifespan and thereby may contribute to 
the cardiorenal protection that has been observed with this 
class of therapeutic agents.100 We currently study whether 
treatment with loop diuretics, thiazides, mineracorticoid re-
ceptor antagonists and/or aquaporin 2 inhibitors similarly 
triggers aestivation motifs for chronic water conservation. 
We conclude that adaptive aestivation metabolism in the 
various body organs is an under- studied research area that, 
besides hypertension and muscle mass loss in chronic renal 
failure, may explain many otherwise unexplainable phe-
nomena in medicine.
4 |  MATERIALS AND METHODS
4.1 | Animal studies 1- 4
The Animal Research Committee of Kagawa University and 
Emory University approved the experimental protocols and 
procedures. We used male Sprague- Dawley (SD) rats (Japan 
SLC Inc, Shizuoka, Japan and Charles River Laboratories, 
Wilmington, MA). The animals were housed under con-
trolled temperature (24°C ± 2°C) and humidity (55% ± 5%) 
on a 12- hour light/dark cycle. We fed the animals rodent 
diets with either 0.2% Na+, 0.9% K+ and 23.1% protein con-
tent (Kagawa University experiments), or with 0.4% Na+, 
1.2% K+ and 28.5% protein content (Emory University 
experiments).
4.2 | Experimental protocol 1
We implanted radiotelemetry transmitters (Data Sciences 
International (DSI), St Paul, MN, USA) into the rats and 
performed a left kidney resection of the upper and lower 
thirds (n = 12) or a sham surgery (n = 6) at 7 weeks of age 
in one surgical procedure. Then, we performed a right uni- 
nephrectomy or a sham surgery at 8 weeks of age. Control 
rats and 5/6Nx rats were provided free access to standard rat 
chow and to tap water. After one week of recovery, we meas-
ured body weight, daily food and water intake. We measured 
the rats’ blood pressure by radiotelemetry on day 0, day 6 and 
day 13 after recovery. On Day 14 after recovery, we placed 
the rats into metabolic cages, collected their urine samples 
and measured their food intake for 24 hours. We terminated 
the experiment after metabolic cage urine collection, sacri-
ficed the rats and harvested tissues.
4.3 | Experimental protocol 2
We performed a left kidney resection of the upper and lower 
thirds (n = 10) or a sham surgery (n = 6) at 7 weeks of age. 
Then, we performed a right uni- nephrectomy or a sham sur-
gery at 8  weeks of age. Control rats and 5/6Nx rats were 
provided free access to standard rat chow and to tap water. 
3 weeks after uni- nephrectomy or sham surgery, we placed 
the rats into metabolic cages, collected their urine samples 
and measured their food intake for 24 hours. We then sacri-
ficed the rats and harvested tissues for western blot, enzyme 
activity assays and metabolome analysis.
4.4 | Experimental protocol 3
We generated control (n = 3) and 5/6Nx (n = 3) rats as de-
scribed above in experimental protocol- 2. At 11 weeks of age, 
we anaesthetized the rats using 1.0%- 3.0% isoflurane and in-
serted an arterial line. We increased room temperature to 33 
degrees, then measured their rectal temperature, heart rate and 
blood pressure every minute for consecutive 30 minutes.
4.5 | Experimental protocol 4
We generated control (n = 5) and 5/6Nx (n = 6) rats as de-
scribed above in the experimental protocol- 2. At 11 weeks of 
age, we anaesthetized the rats using 1.0%- 3.0% isoflurane, in-
creased room temperature to 33 degrees, and measured rectal 
temperature, skin blood velocity/flow/blood mass and transepi-
dermal water loss every six minutes for consecutive 30 minutes.
4.6 | Blood pressure measurements: 
experimental protocol 1
We used a radiotelemetry system (DSI) in experimental pro-
tocol 1 as described previously.101 A radiofrequency trans-
mitter (PA- C40; DSI) and a receiver (RPC- 1; DSI) were 
used to measure blood pressure and heart rate. Data were col-
lected and analysed using Dataquest ART version 4.3 (DSI). 
Experimental protocol 3: We inserted a polyethylene cath-
eter (PE- 60; Becton Dickinson and Company, Sparks, MD, 
USA) into the abdominal aorta via the right femoral artery for 
blood pressure measurement and analysed data using Power 
Lab (PowerLab 8/30; AD Instruments).
4.7 | Urine collection (experimental protocol 
1 and 2)
The rats were placed into metabolic cages with free access 
to regular diet and tap water, and 24 hours of urine volume 
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and fluid intake were measured. All rats underwent a 12- 
hour acclimatization period in metabolic cages before urine 
collection.
4.8 | Electrolyte and osmolality 
measurement (experimental protocol 1 and 2)
Sodium and potassium concentration in plasma and urine was 
measured by using an automated analyser (7020- Automatic 
Analyzer; Hitachi High- Technologies). Plasma and urine 
osmolality were measured by vapour pressure osmometry 
(Wescor).
4.9 | Skin and carcass electrolyte and water 
content (experimental protocol 1)
Skin and carcass samples were desiccated at 90°C for 72- 
hours as described previously.102 Water content was cal-
culated from the difference between wet weight and dry 
weight. We ashed the dry samples at a maximum of 450°C 
for total 92- hours. Then, we further ashed the samples at 
600℃ for 42- hours. We dissolved the skin ashes in 20 mL 
of 10% HNO3 and the carcass ashes in 50 mL of 5% HNO3. 
We measured sodium and potassium concentration of these 
samples by an atomic absorption spectrometer (AA- 7000; 
Shimadzu).
4.10 | Urinary norepinephrine measurement 
(experimental protocol 1)
We collected urine in the tubes including 2% of 6N HCl. 
Urinary norepinephrine concentration was measured using 
high- performance liquid chromatography (FALCO biosys-
tems Ltd).
4.11 | Angiotensin II measurement 
(experimental protocol 1)
We measured Ang II levels of plasma and skin by radioim-
munoassay (RIA) as described in more detail previously.103 
Frozen skin tissues were homogenized in 10  mL ice- cold 
methanol. The homogenate was centrifuged at 3000  rpm 
for 10  minutes, and the supernatant was evaporated over-
night. Then, the evaporated skin samples were solubilized 
in 6 mL of angiotensin assay buffer which is composed of 
50  mmol/L sodium phosphate, 1  mmol/L ethylenediami-
netetraacetate (EDTA), 0.25  mmol/L thimerosal, 2.5  mg/
mL of bovine serum albumin. Additionally, we collected 
blood samples into the tube including the inhibitor cocktails, 
which is composed of 30 μL of 500 mmol/L EDTA, 15 μL 
of 1  mmol/L enalaprilat, and 30  μL of 125  mmol/L o- 
phenanthroline and 0.2  mmol/L pepstatin in 95% ethanol, 
centrifuged at 3000  rpm for 20  minutes, and collected the 
supernatant. We then extracted angiotensin II peptide using 
phenyl- bonded, solid- phase extraction columns from the 
plasma samples (Bond Elut, Agilent Technologies Inc) and 
the skin samples (ISOLUTE, Biotage). Next, the extracted 
samples were evaporated overnight and solved in 500 µL of 
the Angiotensin assay buffer. We finally measured angioten-
sin II peptide by RIA.
4.12 | Copeptin and enzyme activity assay 
(experimental protocol 1 and 2)
Plasma copeptin level (Peninsula Laboratories), Arginase 
(Sigma- Aldrich), malate dehydrogenase (MDH)- 1 (Abcam) 
and aspartate aminotransferase (ASAT) (Abcam) activities 
were measured by commercially available kits according to 
the manufacturers’ protocols. We have described the detailed 
protocol including sample preparation previously.7
4.13 | Western blotting analysis 
(experimental protocol 2)
We quantified protein expression in liver and muscle by 
Western blotting as described previously.7 We used the fol-
lowing commercially available primary antibodies: rabbit 
polyclonal anti- guanidinoacetate N- methyltransferase anti-
body (1:1000; Abcam; ab229467); rabbit polyclonal anti– p– 
acetyl- CoA carboxylase (Ser79) antibody (1:2000 for liver, 
1:6000 for muscle; Cell Signaling Technology, Danvers, 
MA; 3661); rabbit polyclonal anti– p– AMPKα (Thr172) an-
tibody (1:2000 for liver, 1:6000 for muscle; Cell Signaling 
Technology; 4188); rabbit polyclonal anti- AMPKα anti-
body (1:2000 for liver, 1:4000 for muscle; Cell Signaling 
Technology; 1532); and HRP- conjugated anti– β- actin 
(1:10,000; Sigma- Aldrich; A3854) or anti- GAPDH antibody 
(1:10,000; Sigma- Aldrich; G9295).
4.14 | Metabolomic profile analysis 
(experimental protocol 2)
Liquid nitrogen snap- frozen liver and muscle samples from 
6 sham and 10 rats with experimental renal mass reduction 
were aliquoted and used for detection and relative quantifica-
tion of metabolites by Metabolon as previously described.104 
All metabolites except for urea were measured by ultra- 
high- performance LC- MS/MS (UPLC- MS/MS) (Metabolyn; 
Metabolon Inc). We focused on understanding key metabolic 
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components of glucose, amino acid, fatty acid, urea, methyl- 
glycine and purine metabolism.
4.15 | Adaptive circulatory water 
conservation response in the skin (experimental 
protocol 4)
We quantified transepidermal water loss at the hair- removed 
lateral back skin by measuring cutaneous water evaporation 
(VAPO SCAN AS- VT100RS, ASCH JAPAN Co., Ltd). 
The "VAPO SCAN AS- VT100RS" has a closed chamber 
system, which quantifies transepidermal water loss by the 
changes in the absolute humidity in the chamber system in-
dependently of the external environment.105- 107 We quanti-
fied skin blood volume, skin blood flow and skin blood flow 
velocity at the earflap by Doppler sonography (FLO- C1, 
OMEGAWAVE).108 Quantification of transepidermal water 
loss and skin Doppler sonography in experimental animals 
requires anaesthesia, which leads to peripheral vasodilation 
and thereby increases TEWL, reduces body temperature 
and lowers blood pressure. The following adaptive changes 
in skin circulation, cutaneous water conservation and blood 
pressure during our rewarming experiments therefore oc-
curred from a slightly hypothermic starting point.
4.16 | Statistical analysis
We used SPSS Version 25 for data analysis. Data are ex-
pressed as averages ± SD. Data and the statistical analysis 
syntax file are available online at https://data.mende ley.com/
datas ets/4ty47 5fmjy/ draft #folde r- 4b192 be9- 2ab6- 48c1- 
8bee- 1035a e6fc54c
We analysed the relationship between the sum of Na+, K+ 
and urea solutes and total solutes in the urine by linear or 
polynomial regression, and the relationship between urine 
osmolality and urine volume or water intake and urine vol-
ume by polynomial regression. We analysed for differences 
in the relative contribution of Na+, K+ or urea solutes to total 
urine solutes between control and 5/6 Nx rats by multivariate 
General Linear Model analysis (Figure 1).
We analysed the relationship between urine osmolality 
and mean arterial blood pressure, the relationship between 
urine volume and mean arterial pressure, the relationship be-
tween the sum of skin Na++K+ content and skin water con-
tent, and the relationship between the sum of skin Na++K+ 
content and mean arterial blood pressure by linear regression 
in control and in 5/6 Nx rats. In case that both animal groups 
showed comparable relationships, we calculated and plotted 
the regression across both groups. In case that none or only 
one of the groups showed a significant relationship between 
the parameters, we only plot the resulting parameter associa-
tions without reporting a regression line (Figure 2).
Differences in tissue metabolite content between control 
and 5/6 Nx rats were analysed by Welch's Two- Sample t- 
test. We analysed differences in tissue arginase, malate de-
hydrogenase 1 and aspartate aminotransferase activity by 
non- parametric Mann- Whitney U Test. We analysed differ-
ences in guanidinoacetate methyltransferase, phosphorylated 
acetyl- CoA carboxylase and phosphorylated AMP kinase tis-
sue protein level by non- parametric Mann- Whitney U Test 
(if sample not normally distributed), or by unpaired T- Test 
(if sample normally distributed), depending on the result of 
One- Sample Kolmogorov- Smirnov- Test for normal distribu-
tion (Figures 3 and 4).
We analysed differences in plasma copeptin, skin angio-
tensin II, 24 urine norepinephrine and plasma angiotensin 
II levels between control and 5/6 Nx rats by multivariate or 
univariate General Linear Model analysis. We analysed the 
difference in body temperature, mean arterial blood pressure, 
skin blood volume, transepidermal water loss, skin blood flow 
velocity and skin blood flow between control rats and 5/6 Nx 
rats in response to increased environmental temperature by 
General Linear Model for Repeated Measurements analysis 
(univariate ANOVA analysis) (Figure 5 and Figure S3).
We analysed the differences in 24- hours urine solute and 
water excretion and the differences in tissue Na+, K+ and 
water content between control and 5/6 Nx rats by multivariate 
General Linear Model analysis (Tables 1 and 2).
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